Jillian Rork is a Dermatology physician affiliated with Dartmouth College. OpenAlex indexes 37 publications with 441 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Hitchcock Way
Manchester, NH 031044125
Telephone
603-695-2500Provider last certified this registry record 15 Dec 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
73.3%Azole Antifungal44.4%Ketoconazole100%Part D<11 patientsLincosamide Antibacterial28.9%Clindamycin Phosphate100%Part D<11 patientsDermatology
26.7%Azole Antifungal26.7%Jublia100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Down syndrome and Psoriasis: An Investigation of Cardiometabolic Risk
Dartmouth-Hitchcock Clinic
FY2025$155,000R03HL173741 - Down syndrome and Psoriasis: An Investigation of Cardiometabolic Risk
Dartmouth-Hitchcock Clinic
FY2024$155,000R03HL173741
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multi-center comparison of hidradenitis suppurativa (HS) among children with and without Down syndrome (DS)
Journal of Investigative Dermatology
2026 - Psoriasis Management in the Down Syndrome Population: A Retrospective Cohort Study Using the Epic Cosmos Dataset
Journal of Investigative Dermatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Tyler Curiel, MD
Dartmouth College
Philip Goodney, MD
Dartmouth College
Richard Rothstein, MD
Dartmouth College
Marcus Shaker, MD
Dartmouth College
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”